Polar Capital Funds PLC - Biotechnology Fund I Inc
Category Sector Equity Biotechnology
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£53.85/£53.85
£-0.88 (-1.61%)
Fund Code
POBII
B42P0H7
IE00B42P0H75
Prices updated as at 23 Apr 2026
Prices in GBP
Investment objective
The investment objective of the Fund is to achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of biotechnology, diagnostics and life sciences tools companies.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Portfolio as of 28/02/2026
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Small growth
38.35%
% Weight
Value
Core
Growth
Large
6
2
12
Medium
0
8
14
Small
0
20
38
Valuation
Polar Capital Funds PLC - Biotechnology Fund I Inc
Sector Equity Biotechnology
25.40
1.83
4.59
15.23
Growth rate
Polar Capital Funds PLC - Biotechnology Fund I Inc
Sector Equity Biotechnology
11.58%
0.14%
6.57%
Top 10 holdings
1
Northern Trust Global US Dollar F
Sector
-
Country
Ireland
% of assets
9.06222
2
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
4.93604
3
Arcutis Biotherapeutics Inc Ordinary Shares
Sector
-
Country
United States
% of assets
4.54988
4
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.48354
5
UCB SA
Sector
-
Country
Belgium
% of assets
4.17113
6
Ascendis Pharma AS ADR
Sector
-
Country
Denmark
% of assets
3.93918
7
Madrigal Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.71683
8
Revolution Medicines Inc Ordinary Shares
Sector
-
Country
United States
% of assets
3.44218
9
BridgeBio Pharma Inc
Sector
-
Country
United States
% of assets
3.36458
10
argenx SE
Sector
-
Country
United States
% of assets
3.27362
Assets in top 10 holdings %
44.94%
Total no. of equity holdings
47.00
Total no. of bond holdings
-
Stock sectors
Polar Capital Funds PLC - Biotechnology Fund I Inc
Sector Equity Biotechnology
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
100.00%
Con defensive
Healthcare
Utilities